Alan Emel, Liman Narin, Sağsöz Hakan
Department of Histology and Embryology, Faculty of Veterinary Medicine, University of Erciyes, 38039, Kayseri, Turkey,
Vet Res Commun. 2015 Jun;39(2):115-35. doi: 10.1007/s11259-015-9633-6. Epub 2015 Mar 11.
The epidermal growth factor (EGF) plays a crucial role in the control of uterine cell proliferation, growth and differentiation. This study was designed to investigate the spatiotemporal expression pattern and localization of the EGF receptor/ligand system during the process of uterine involution using immunohistochemistry. Our results indicated that the expression of the ErbB/HER receptors and their ligands varied with structural changes in the uterus at different days of involution. Supranuclear punctate ErbB1 immunostaining was observed in the luminal and glandular epithelial cells and endometrial fibroblasts. Moderate ErbB2/HER2 immunoreactivity was observed in the lateral membrane and cytoplasm of the epithelial cells on the 1st, 3rd and 5th days and was decreased on the other days of involution. The amount of nuclear and cytoplasmic ErbB3/HER3 and ErbB4/HER4 immunostaining remained constant throughout the postpartum period. The EGF immunoreaction was weak in the luminal and glandular epithelium throughout the involution period. Although the cytoplasmic AREG immunoreactivity in the glandular epithelium was stronger on the 1st and 3rd days compared with the other days of involution, NRG1 immunostaining was weak on the 1st and 3rd days and was moderate in the apical cytoplasm on the 10th and 15th days of involution. The macrophages displayed strong cytoplasmic immunoreactivity for ErbB3/HER3, ErbB4/HER4, EGF, AREG and NRG. Strong, moderate and weak immunostaining for ErbB2/HER2, ErbB4/HER4 and other proteins (ErbB1, ErbB3, AREG and NRG), respectively, was present in the myometrial smooth muscle cells. These findings support the hypothesis that the EGFsystem plays a role in the development of various physiological changes associated with uterine involution.
表皮生长因子(EGF)在子宫细胞增殖、生长和分化的调控中起着关键作用。本研究旨在利用免疫组织化学方法研究子宫复旧过程中表皮生长因子受体/配体系统的时空表达模式和定位。我们的结果表明,ErbB/HER受体及其配体的表达随子宫复旧不同天数的结构变化而变化。在腔上皮细胞、腺上皮细胞和子宫内膜成纤维细胞中观察到核上点状ErbB1免疫染色。在第1、3和5天,上皮细胞的侧膜和细胞质中观察到中等强度的ErbB2/HER2免疫反应,在复旧的其他天数则减弱。在整个产后期间,核内和胞质内的ErbB3/HER3和ErbB4/HER4免疫染色量保持恒定。在整个复旧期间,腔上皮和腺上皮中的EGF免疫反应较弱。虽然腺上皮中细胞质AREG免疫反应在第1和3天比复旧的其他天数更强,但NRG1免疫染色在第1和3天较弱,在复旧的第10和15天,顶端细胞质中的NRG1免疫染色为中等强度。巨噬细胞对ErbB3/HER3、ErbB4/HER4、EGF、AREG和NRG表现出强烈的细胞质免疫反应。子宫肌层平滑肌细胞中分别对ErbB2/HER2、ErbB4/HER4和其他蛋白(ErbB1、ErbB3、AREG和NRG)呈现强、中、弱免疫染色。这些发现支持了EGF系统在与子宫复旧相关的各种生理变化发展中起作用的假说。